ANTHARIS THERAPEUTICS
Live / Applied — Final refusal mailed (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 06 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99222134
- Mark type
- Design + words
- Filed
- 06 Jun 2025
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Biologics in the nature of pharmaceutical preparations for immunotherapy against cancer; Pharmaceutical and biological preparations for medical therapeutic use in oncology, immunology, and immuno-oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing tumors, cancer, and inflammatory disorders; Therapeutic agents for medical use, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, and engineered antibodies for increasing T-cell activation, increasing phagocytosis, reducing cytokine release, and suppressing over expressing tumors and cancer cells
- Class 040 — Treatment of materials: Custom manufacturing of therapeutic agents, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion molecular proteins, and engineered antibodies, all for use in pharmaceuticals
- Class 042 — Scientific and technological services: Research and development in the fields of immune-oncology, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion molecular proteins, and pharmaceuticals and biologics in the field of oncology; Providing medical research information in the fields of monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and pharmaceuticals and biologics in the field of oncology
Owner
- Antharis Therapeutics Holdings Inc., Vista, NY, US
Prosecution history
- 12 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Mar 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 04 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 04 Mar 2026 — FINAL REFUSAL E-MAILED
- 04 Mar 2026 — FINAL REFUSAL WRITTEN
- 03 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — NON-FINAL ACTION WRITTEN
- 28 Oct 2025 — ASSIGNED TO EXAMINER
- 13 Oct 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 13 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED